BCM
XRAY icon

BlueCrest Capital Management’s Dentsply Sirona XRAY Stock Holding History

BlueCrest Capital Management’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,166
Closed -$275K – 618
2019
Q3 		$275K Buy
+5,166
New +$277K 0.02% 392
2016
Q1 		– Sell
-12,989
Closed -$790K – 1157
2015
Q4 		$790K Buy
+12,989
New +$773K 0.03% 474

Other funds holding XRAY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

BlueCrest Capital Management's XRAY Position: Q4 2019 in Review

BlueCrest Capital Management sold out of Dentsply Sirona (XRAY) in Q4 2019, closing a stake of 5,166 shares — an estimated $275K sold.

BlueCrest Capital Management first reported a position in XRAY in Q4 2015 and held it in 2 quarters. The position peaked at $790K in Q4 2015. 559 funds tracked by Wall St. Rank hold XRAY as of Q4 2019.

  • BlueCrest Capital Management reported no remaining Dentsply Sirona position as of Q4 2019 after selling out during the quarter.
  • BlueCrest Capital Management sold 5,166 Dentsply Sirona shares in Q4 2019, an estimated $275K.
  • BlueCrest Capital Management first reported a position in Dentsply Sirona in Q4 2015 and held it in 2 quarters.
  • BlueCrest Capital Management's Dentsply Sirona position peaked at $790K in Q4 2015.
  • 559 funds tracked by Wall St. Rank held Dentsply Sirona as of Q4 2019.

Based on BlueCrest Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.